Patents by Inventor Enrico Salomi

Enrico Salomi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carrier particles for dry powder formulations for inhalation
    Patent number: 10709666
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: July 14, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca Schiaretti, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20200163883
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca Schiaretti, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • Carrier particles for dry powder formulations for inhalation
    Patent number: 10583085
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: March 10, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca Schiaretti, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi
  • NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20180333359
    Abstract: Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
    Type: Application
    Filed: May 14, 2018
    Publication date: November 22, 2018
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Francesca SCHIARETTI, Francesca Buttini, Ruggero Bettini, Enrico Salomi, Andrea Benassi